PARIS--(BUSINESS WIRE)--LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an ...

Paris, France – XX February 2022: NovoBiome ("the Company"), a drug discovery company developing breakthrough Live Biotherapeutics Products (LBPs) 1 targeting the microbiome-gut-liver axis, announces ...

BioData has announced the roll-out of its Electronic Lab Notebook (ELN) platform, Labguru, with Inserm, France’s only public research institute to focus entirely on human health. Inserm made the ...

Please provide your email address to receive an email when new articles are posted on . Almirall S.A. and Inserm Transfert have entered an agreement to advance research in vitiligo treatment, the two ...

Tonix Pharmaceuticals has licensed oxytocin-based therapeutic technology for the treatment of rare genetic disorder Prader-Willi syndrome. The agreement with French research institute Inserm continues ...

Heart failure affects over one million people in France. Although the blood system is the first to have been explored for the purpose of improving heart function, a study by Inserm has revealed the ...

To achieve these objectives, the partners will unite their scientific teams and pool their expertise and know-how to transform innovative projects into programs ready for industrial development. As ...

Hamburg, Germany, 30 May 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the Company entered a partnership with Inserm, the French ...

Global artificial intelligence (AI) company, Expert System has announced that the French National Institute of Health and Medical Research, Inserm, will implement its Clinical Research Navigator (CRN) ...

AstraZeneca and the French National Institute of Health and Medical Research (Inserm) have entered a collaboration to investigate new therapeutic approaches to type 2 diabetes and chronic kidney ...